WHITLEY WHYTE: Open Payments
NPI 1154009082 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,057 in 130 payments from 22 companies in 2025. Trend: 2023 $706 · 2024 $2,492 · 2025 $3,057
Food & beverage: $3,014Education: $43
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $414 |
| GENZYME CORPORATION | 10 | $325 |
| GlaxoSmithKline, LLC. | 17 | $263 |
| JAZZ PHARMACEUTICALS INC. | 9 | $234 |
| AstraZeneca Pharmaceuticals LP | 6 | $208 |
| Actelion Pharmaceuticals US, Inc. | 6 | $171 |
| Insmed, Inc. | 10 | $169 |
| Viatris Specialty LLC | 9 | $160 |
| Verona Pharma, Inc. | 7 | $156 |
| Grifols USA, LLC | 7 | $146 |
Products named: DUPIXENT, XYWAV, YUPELRI, NUCALA, Ohtuvayre, Arikayce, Prolastin-C Liquid, OFEV.
Industry payments across FL — which companies pay providers there.
